| |
|
|
|
ImmuCell Corporation  
|
|
5.94 -0.06 (-0.01%) |
04-18 15:55 |
|
Open: |
6.04 |
Pre close: |
6 |
Target:
|
7.49
|
|
High: |
6 |
Low: |
5.91 |
Resistance:
|
6.42
6.95
|
|
Volume: |
6,193 |
Market Cap: |
43M |
Support:
|
5.55
4.62
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.16
 |
MACD |
MACD(12,26):
|
-0.20 |
|
MA(20): |
6.32 |
Signal(12,26,9): |
-0.19 |
|
MA(100): |
7.04 |
Stochastic Oscillator |
%K(14,3):
|
26.29 |
|
MA(250): |
7.26 |
%D(3): |
43.33 |
|
Average Volume(K) |
3-Month: |
900
|
52-Week |
High:
|
9.30 |
|
10-Days: |
831 |
Low: |
5.55 |
|
RSI |
RSI(14):
|
37.68 |
Change(%): |
-18.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-10.5 |
Shares Out. (M) |
7.21 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-7.1 |
Shares Float (M) |
5.72 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-6.2 |
% Held by Institutions |
15.50 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.970 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.02 |
|
Profit Margin |
-25.49 |
Operating Cash Flow
(M) |
-0.37 |
P/S |
21413700.00 |
|
Operating Margin |
-19.54 |
Levered Free Cash Flow
(M) |
-2.49 |
P/CF |
-114.69 |
|
|
|
|
|
|
